Companies & Industry »Company News»Company News Details
Company News Details

BSE   15 Dec 17 | 12:00 AM

410.30 0.95 (0.23%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   15 Dec 17 | 12:00 AM

411.20 1.55 (0.38%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 417.10 (-1.63%)
1 Month : Rs 446.35 (-8.08%)
1 Year : Rs 376.05 (9.11%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

Widgets Magazine

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Widgets Magazine

Sensex

Company Price Gain (%)
M & M1,482.653.56
Coal India271.053.02
Dr Reddy's Labs2,372.002.52
HDFC Bank1,873.051.95
Adani Ports401.951.75

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine